This Week in Washington IP: What the United States Can Learn from the Downturn in Japan’s Pharmaceutical Industry, IP as a Business Strategy, and Increasing Equity through Federal Policy

Washington IPThis week in Washington IP news, Congress is out of town thanks to a state work period, but there are still several interesting events related to the IP world. The Information Technology and Innovation Foundation (ITIF) is hosting an event on the downfall of Japan’s pharmaceutical industry. Elsewhere, New America will hear from several former White House officials on implementing federal legislation that sought to increase equity.

Monday, April 3

Center for Strategic and International Studies

Launch Event: Wadhwani Center for Artificial Intelligence and Advanced Technologies

At 3:00 PM on Monday, online livestream

On Monday, the CSIS is holding a launch event for the Wadhwani Center which plans to focus on providing policymakers with the quickly evolving field of AI. The center is being funded by Silicon Valley entrepreneur Dr. Romesh Wadhwani’s non-profit. The new director of the center Gregory C. Allen and Dr. Wadhwani will discuss their mission and plans at the event

Tuesday, April 4

New America

Making Equity Work Through the Federal Government

At 10:00 on Tuesday, 740 15th St NW #900 and online livestream

On Tuesday, New America is hosting this discussion on how the federal government can achieve its equity goals with recent White House leaders. The panelists will walk through their experience with implementing federal legislation including the Executive Order on Further Advancing Racial Equity and Support for Underserved Communities. Speakers include Dr. Sabeel Rahman, Former Associate Administrator, Office of Information and Regulatory Affairs, OMB, Dr. Clarence Wardell. Former Senior Advisor for Policy Implementation & Delivery, Domestic Policy Council, and Dr. Kimberlyn Rachael Leary Former Senior Policy Advisor, Domestic Policy Council, OMB.

Information Technology and Innovation Foundation

Lessons From the Rise and Fall of Japan’s Life-Sciences Innovation Ecosystem

At noon on Tuesday, 700 K St NW Suite 600 and online livestream

On Tuesday, the ITIF is hosting a panel discussion on Japan’s decline in the pharmaceutical sector. Japan produced about 30% of all new drugs in the ‘80s, but this share has dropped by more than 70%. In addition to a lack of funding in research and innovation, the panel will discuss the country’s policy decisions and what lessons can be learned for other countries including the United States.

Wednesday, April 5

U.S. Patent and Trademark Office

Intellectual Property (IP) strategy is a business strategy

At noon Wednesday, online video webinar

On Wednesday, the USPTO is hosting this event in collaboration with the Arizona Small Business Development Center (SBDC) Network to inform entrepreneurs and innovators about the value of an IP strategy. The event will discuss patents, trademarks, copyrights, and trade secrets and familiarize you with the new IP Identifier tool. The USPTO will provide additional information to prospective IP holders, so they can incorporate IP into their business strategy.

Thursday, April 6

IPWatchdog

Raising the Profile of IP within Your Company – Sponsored by Anaqua

At 11:00 AM on Thursday, online video webinar

On Thursday, join this conversation about how IP leaders can and should discuss their efforts with decision-makers in the C-suite and on the Board of Directors. The event will focus on how best to engage company teams and senior management on the importance of intellectual property protection as a driver of value and not as a cost center for the company. President & CEO of IPWatchdog, Inc. Gene will be joined by Christof Wolpert, Vice President Global Legal Innovation, Adidas, Raymond Millien, VP of Legal at Exro Technologies Inc., and Vincent Brault, Senior Vice President of Product & Innovation at Anaqua.

Share

Warning & Disclaimer: The pages, articles and comments on IPWatchdog.com do not constitute legal advice, nor do they create any attorney-client relationship. The articles published express the personal opinion and views of the author as of the time of publication and should not be attributed to the author’s employer, clients or the sponsors of IPWatchdog.com.

Join the Discussion

No comments yet.